| abstract |
[PROBLEMS] To provide a stent coated with an anti-restenotic drug. SOLUTION: The anti-restenotic drug is Alkeran (Al keran), Cytoxan, Leuker an), cis-platinum, vi BiCNU, Adriamyci n), Doxorubicin, Servidin (Ce) rubidine), Idamycin, Mithracin, Mutamycin, Fluorouracil, Methotrexate (Methot) rexate), toguanine (Thoguanine), toxotere (Toxotere), etoposide (Etoposide), vincristine (Vincristine), irinotecan (Irinotecan), Hycamptin, Matulan e) selected from the group including: |